You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et récemment mises à jour, ainsi que les fiches de renseignements sur les patients et les documents de sécurité et de conseils.

Drug

Published Date: 26 Feb 2026

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, Administration, and Special Precautions sections
Updated
Feb 2026
Drug

Published Date: 26 Feb 2026

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, Administration, and Special Precautions sections
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d'information mise à jour/revisée)
Updated
Feb 2026
Regimen
Published Date: 26 Feb 2026
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Adverse Effects and Administration sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Neoadjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Gynecologic, 
Cervix
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Drug Administration/Special Precautions sections

Updated
Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Drug Administration/Special Precautions sections

Updated
Feb 2026
Drug

Published Date: 25 Feb 2026

Revision Summary:
Drug Monograph: Updated Administration and Supplementary Public Funding sections
Updated
Feb 2026

Pages